Our Work
We are on a mission to transform outcomes for people with mental health conditions by developing rapid-acting, durable and convenient treatments
Our Pipeline
We aim to develop novel and effective mental health treatments for large-scale patient impact.
Therapeutic Focus
We target mental health indications with significant unmet patient needs, where existing treatments fall short.
Publications
We have developed a robust body of evidence that highlights the potential of psychedelic-based neuroplastogens to be transformative treatments for mental health conditions.
Clinical Trials
We are running several clinical trials to investigate our proprietary treatments. Learn more about our ongoing studies, as well as the results from our completed trials.